IGENE Biotechnology Inc. (IGNE)

MATERIALS: CHEMICALS
SIC: AGRICULTURAL CHEMICALS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

9110 RED BRANCH RD COLUMBIA, MD 21045-2024

Igene Biotechnology Inc. develops, markets and manufactures specialty ingredients for human and animal nutrition. The company is a supplier of natural astaxanthin, an essential nutrient in different feed applications and a source of pigment for coloring farmed salmon species. It also supplies nutraceutical ingredients.

Data based on most recent fiscal year report
Market Cap1.103 Million Shares Outstanding110.34 Million Avg Volume33.386 Thousand
1-Yr BETA vs S&P TR Current Ratio1.5 Quick Ratio0.48
View SEC Filings from IGNE instead.
Q2 2019 All Institutions Hedge Funds 1
To trade IGNE now:
No data found for this quarter.
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IGNE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KEMPNER THOMAS L

0 2018-05-30 0

KIMELMAN MICHAEL CHAIRMAN OF THE BOARD

  • Officer
  • Director
133,055,918 2010-10-20 0

HIU STEPHEN F PRESIDENT

  • Officer
  • Director
11,526,633 2009-07-16 0

MONAHAN PATRICK F

  • Director
  • SECRETARY
7,670,400 2009-07-16 0

WEISEBERGER EDWARD J CHIEF FINANCIAL OFFICER

  • Officer
4,049,697 2009-07-16 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments